• Home
  • Reagents
    • Overview
    • Primary Antibodies
      • Overview
      • Anti-Allergen Antibodies
      • Anti-Coronavirus Antibodies
      • Anti-Virus Antibodies
      • Antibodies to Epitope Tags
      • Murine Bispecific Antibody Reagents
      • DNA/RNA Research Antibodies
      • Recombinant Isotype Controls
      • Tumor Marker Antigens
      • Recombinant Antibodies from Human Patients
      • Immunotherapy Research Antibodies
      • Research-Grade Biosimilars
      • VivopureX™ Antibodies for In Vivo Research
    • Secondary Antibodies
      • Anti-Human Immunoglobulin Antibodies
      • Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies
      • Other Secondary Antibodies
    • Recombinant Proteins
      • Overview
      • Veterinary IgE Fc Proteins
      • Fc Fusion Proteins
      • Immunoglobulin Fc domains (Ig Fc domains)
      • Multi-Tag Control Proteins
      • Recombinant Free Light Chains
  • Services
    • Overview
    • Antibody Engineering
      • Overview
      • Antibody Humanization Service
      • Bispecific and Trispecific Antibodies
    • Antibody Sequencing
      • Overview
      • Hybridoma Sequencing
      • Antibody Protein Sequencing
      • Polyclonal Antibody Sequencing
    • Antibody Expression
      • Overview
      • HEXpress™ HEK Antibody Production
      • CHXpress™ CHO Antibody Production
      • FleXpress™ High-Throughput Antibody Production
  • Our Technology
    • Why go recombinant?
    • Our Recombinant Technology
    • Our Customers
      • Pharma/Biotech
      • Diagnostic Developers
      • Academic Researchers
    • Formats We Have Made
      • Non-IgG Isotypes
      • Chimeric Antibodies
      • Antibody Fragments
      • Fc Silent™ Antibodies
      • mAbsolve Fc Silencing Technology
      • Periodic Table of Antibodies
    • License Your Antibodies
    • Animal-Free Antibodies
  • About Us
    • Overview
    • Our Management Team
    • Our Sister Company
    • Testimonials & Case Studies
    • ISO Certification
    • Careers
    • Contact Us
  • Antibody Resource
    • Overview
    • Antibody Overview
    • Antibody Engineering
    • External Resources
  • News & Events
    • Events
    • Blog
    • In the News
    • Newsletter
    • Publications
    • Company Resources
  • How to Order
    • Direct Order
    • Distributors
  • Contact us
  • FAQs
£0.00
0 items
  • Contact us
  • FAQs
United Kingdom (UK)
  • United States (US)
  • United Kingdom (UK)
  • Germany
  • Canada
  • Austria
  • Belgium
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Gibraltar
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Monaco
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Other countries
£0.00
0 items
Menu
  • Home
  • Reagents
    • Overview
    • Primary Antibodies
      • Overview
      • Anti-Allergen Antibodies
      • Anti-Coronavirus Antibodies
      • Anti-Virus Antibodies
      • Antibodies to Epitope Tags
      • Murine Bispecific Antibody Reagents
      • DNA/RNA Research Antibodies
      • Recombinant Isotype Controls
      • Tumor Marker Antigens
      • Recombinant Antibodies from Human Patients
      • Immunotherapy Research Antibodies
      • Research-Grade Biosimilars
      • VivopureX™ Antibodies for In Vivo Research
    • Secondary Antibodies
      • Anti-Human Immunoglobulin Antibodies
      • Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies
      • Other Secondary Antibodies
    • Recombinant Proteins
      • Overview
      • Veterinary IgE Fc Proteins
      • Fc Fusion Proteins
      • Immunoglobulin Fc domains (Ig Fc domains)
      • Multi-Tag Control Proteins
      • Recombinant Free Light Chains
  • Services
    • Overview
    • Antibody Engineering
      • Overview
      • Antibody Humanization Service
      • Bispecific and Trispecific Antibodies
    • Antibody Sequencing
      • Overview
      • Hybridoma Sequencing
      • Antibody Protein Sequencing
      • Polyclonal Antibody Sequencing
    • Antibody Expression
      • Overview
      • HEXpress™ HEK Antibody Production
      • CHXpress™ CHO Antibody Production
      • FleXpress™ High-Throughput Antibody Production
  • Our Technology
    • Why go recombinant?
    • Our Recombinant Technology
    • Our Customers
      • Pharma/Biotech
      • Diagnostic Developers
      • Academic Researchers
    • Formats We Have Made
      • Non-IgG Isotypes
      • Chimeric Antibodies
      • Antibody Fragments
      • Fc Silent™ Antibodies
      • mAbsolve Fc Silencing Technology
      • Periodic Table of Antibodies
    • License Your Antibodies
    • Animal-Free Antibodies
  • About Us
    • Overview
    • Our Management Team
    • Our Sister Company
    • Testimonials & Case Studies
    • ISO Certification
    • Careers
    • Contact Us
  • Antibody Resource
    • Overview
    • Antibody Overview
    • Antibody Engineering
    • External Resources
  • News & Events
    • Events
    • Blog
    • In the News
    • Newsletter
    • Publications
    • Company Resources
  • How to Order
    • Direct Order
    • Distributors

Home Our Technology

Our Technology

Recombinant antibodies are absolutely defined by their amino acid sequence and manufactured in vitro using synthetic genes. Though recombinant antibodies are standard in the pharmaceutical industry, these antibodies have not been as widely available for research and diagnostics applications. This is starting to change, however, due to the significant benefits recombinant antibodies offer over traditional hybridoma-produced monoclonal antibodies.

Absolute Antibody was founded in 2012 with a vision to make recombinant antibodies accessible to all, and we remain the only company 100% focused on recombinant antibody technology. Follow the links below to learn more about recombinant antibodies and the recombinant antibody solutions we offer to customers worldwide.

Why Go Recombinant?

Discover the advantages of using recombinant antibodies over traditional antibodies.
Find out more

Our Recombinant Technology

Learn about our proprietary platforms for rapid antibody sequencing, reformatting and production.
Find out more

Our Customers

Read about the different industries we serve with recombinant antibody technology, including pharmaceuticals, biotech, diagnostics and academic research.
Find out more

Formats We Have Made

View the many antibody formats we have produced for our customers – more than 100 and counting!
Find out more

License Your Antibodies

Learn why research institutions license their lab-made antibodies to us for recombinant production.
Find out more

Animal-Free Antibodies

The recombinant production platform we use at Absolute Antibody is completely animal and animal-component free.
Find out more
Queen's Award For Enterprise
Subscribe to our e-newsletter
Twitter
LinkedIn

Explore this site

Primary Antibodies
  • Neuroscience
  • Anti-Allergen Antibodies
  • Anti-Coronavirus Antibodies
  • Anti-Virus Antibodies
  • Antibodies to Epitope Tags
  • Bispecific Antibody Reagents
  • DNA/RNA Research Antibodies
  • Recombinant F4/80 Clone CI:A3-1
  • Recombinant Isotype Controls
  • Tumor Marker Antigens
  • Recombinant Antibodies from Human Patients
  • Immunotherapy Research Antibodies
  • Research-Grade Biosimilars
  • VivopureX™ Antibodies for In Vivo Research
  • Other Products
Secondary Antibodies
  • Anti-Human Immunoglobulin Antibodies
  • Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies
  • Other Secondary Antibodies
Recombinant Proteins
  • Veterinary IgE Fc Proteins
  • Fc Fusion Proteins
  • Immunoglobulin Fc domains (Ig Fc domains)
  • Multi-Tag Control Protein
  • Recombinant Free Light Chains

Copyright © 2023 Absolute Antibody. All rights reserved

  • Careers
  • Terms and Conditions
  • Privacy Policy

Website design by Electric Studio - Digital WordPress Agency Oxford